Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US8740602052
12,80 € ↓ -0,10 (-0,78%)
2026-06-04
AKTIENPREIS
SecurityDE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
InstitutionWalleye Trading LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Walleye Trading LLC ownership in TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)

On May 8, 2026 - Walleye Trading LLC filed a 13F-HR form disclosing ownership of 0 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) (DE:TKDA) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 27,062 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock). This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Walleye Trading LLC has a history of taking positions in derivatives of the underlying security (TKDA) in the form of stock options. The firm currently holds call options representing 96,400 of underlying shares valued at $1,785,328 USD and put options representing 40,500 of underlying shares valued at $750,060 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 0 -27,062 -100.00 0 -100.00
2026-02-13 2025-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 27,062 21,264 366.75 422 401.19 0.0006
2025-11-14 2025-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 5,798 5,798 85 0.0001
2025-02-13 2024-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 0 -76 -100.00 0 -100.00
2024-11-14 2024-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 76 76 1 0.0000
2024-08-14 2024-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 0 -6,988 -100.00 0 -100.00
2024-05-15 2024-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 6,988 -24,812 -78.03 97 -78.59 0.0002
2024-02-14 2023-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 31,800 -120,504 -79.12 454 -80.77 0.0010
2023-11-21 2023-09-30 13F/A-1 TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 152,304 152,304 2,356 0.0062
2020-05-15 2020-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 0 -678,737 -100.00 0 -100.00
2020-02-14 2019-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 678,737 242,099 55.45 13,391 78.31 0.0926
2019-11-14 2019-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 436,638 -131,831 -23.19 7,510 -25.36 0.0641
2019-08-14 2019-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 568,469 -292,108 -33.94 10,062 -42.60 0.0869
2019-05-15 2019-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 860,577 860,577 17,530 0.1361
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 96,400 -3.21 1,785 15.01 n/a n/a n/a
2026-02-13 2025-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 99,600 1,553 n/a n/a n/a
2025-08-13 2025-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-14 2025-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 26,900 -35.34 400 -27.27 n/a n/a n/a
2025-02-13 2024-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 41,600 163.29 551 145.54 n/a n/a n/a
2024-11-14 2024-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 15,800 -78.82 225 -76.79 n/a n/a n/a
2024-08-14 2024-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 74,600 26.01 965 17.40 n/a n/a n/a
2024-05-15 2024-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 59,200 -28.93 822 -30.81 n/a n/a n/a
2024-02-14 2023-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 83,300 245.64 1,189 219.35 n/a n/a n/a
2023-11-21 2023-09-30 13F/A TAKEDA PHARMACEUTICAL SPONSORED ADS Call 24,100 151.04 373 148.00 n/a n/a n/a
2023-11-14 2023-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 24,100 373 n/a n/a n/a
2023-08-14 2023-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 9,600 -59.66 151 -61.73 n/a n/a n/a
2023-05-15 2023-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 23,800 230.56 392 250.00 n/a n/a n/a
2023-02-14 2022-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 7,200 -90.90 112 -89.08 n/a n/a n/a
2022-11-14 2022-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 79,100 13.32 1,026 4.69 n/a n/a n/a
2022-08-08 2022-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 69,800 472.13 980 460.00 n/a n/a n/a
2022-05-16 2022-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 12,200 -86.56 175 -85.86 n/a n/a n/a
2022-02-14 2021-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 90,800 20.26 1,238 0.08 n/a n/a n/a
2021-11-15 2021-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 75,500 -50.97 1,237 -52.28 n/a n/a n/a
2021-08-16 2021-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 154,000 -10.10 2,592 -17.14 n/a n/a n/a
2021-05-17 2021-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 171,300 141.61 3,128 142.48 n/a n/a n/a
2021-02-16 2020-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 70,900 1,290 n/a n/a n/a
2020-05-15 2020-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 992,173 4.82 19,576 20.24 n/a n/a n/a
2019-11-14 2019-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 946,573 -19.10 16,281 -21.39 n/a n/a n/a
2019-08-14 2019-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 1,170,093 22.05 20,711 6.05 n/a n/a n/a
2019-05-15 2019-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Call 958,718 19,529 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 40,500 -37.79 750 -26.04 n/a n/a n/a
2026-02-13 2025-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 65,100 161.45 1,015 178.57 n/a n/a n/a
2025-11-14 2025-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 24,900 365 n/a n/a n/a
2025-08-13 2025-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-14 2025-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 20,000 300.00 297 350.00 n/a n/a n/a
2025-02-13 2024-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 5,000 -66.89 66 -69.16 n/a n/a n/a
2024-11-14 2024-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 15,100 215 n/a n/a n/a
2024-08-14 2024-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 25,400 -46.30 353 -47.77 n/a n/a n/a
2024-02-14 2023-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 47,300 -70.46 675 -72.78 n/a n/a n/a
2023-11-21 2023-09-30 13F/A TAKEDA PHARMACEUTICAL SPONSORED ADS Put 160,100 -43.29 2,477 -44.16 n/a n/a n/a
2023-11-14 2023-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 160,100 2,477 n/a n/a n/a
2023-08-14 2023-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 282,300 15.79 4,435 10.38 n/a n/a n/a
2023-05-15 2023-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 243,800 35.52 4,018 43.16 n/a n/a n/a
2023-02-14 2022-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 179,900 -4.97 2,806 14.30 n/a n/a n/a
2022-11-14 2022-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 189,300 1,793.00 2,455 1,653.57 n/a n/a n/a
2022-08-08 2022-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 10,000 -77.01 140 -77.53 n/a n/a n/a
2022-05-16 2022-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 43,500 -14.54 623 -10.23 n/a n/a n/a
2022-02-14 2021-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 50,900 -29.89 694 -41.63 n/a n/a n/a
2021-11-15 2021-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 72,600 830.77 1,189 807.63 n/a n/a n/a
2021-08-16 2021-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 7,800 0.00 131 -7.75 n/a n/a n/a
2021-05-17 2021-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 7,800 1.30 142 1.43 n/a n/a n/a
2021-02-16 2020-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 7,700 140 n/a n/a n/a
2020-05-15 2020-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 484,145 0.00 9,552 14.71 n/a n/a n/a
2019-11-14 2019-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 484,145 -54.25 8,327 -55.54 n/a n/a n/a
2019-08-14 2019-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 1,058,168 -10.61 18,730 -22.32 n/a n/a n/a
2019-05-15 2019-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 1,183,762 24,113 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.